Nucleic acid extraction lies at the beginning of almost every molecular biology-based workflow. Although the principle behind it is simple, when done poorly, it can have a significant impact on final experimental results. If working with patient samples, maintaining sample integrity becomes even more essential and reliable results are paramount to ensuring a fast and accurate diagnosis.
Timely Identification, Tracking and Mitigation of Future Outbreaks | We could have prevented the SARS-CoV-2 outbreak from developing into a pandemic, but we did not have an adequate surveillance system that could detect novel threats, particularly those that can be carried by asymptomatic carriers.
Bill Venier, M.Sc, TS, ELD (ABB) and Deb Venier, MS, TS, of World Embryology Skills and Training (W.E.S.T.) draw from their many years of experience in the embryology lab to discuss their perspective on non-invasive PGT-A.
The PerkinElmer® COVID-19 Antigen Test has been approved by the National Sanitary Surveillance Agency of Brazil (ANVISA) as a Class III in vitro diagnostic (IVD) device. This approval authorizes the sale, distribution, and use of PerkinElmer’s 15-minutes antigen test in Brazil for the qualitative detection of SARS-CoV-2, with nasal or nasopharyngeal swabs. The PerkinElmer® COVID-19 Antigen test is an accurate and efficient product to screen for the presence of COVID-19.
Identifying the Delta VOC (B.1.617) with the NEXTFLEX® Variant-Seq™ SARS-CoV-2 Kit | On May 10, 2021, the World Health Organization (WHO) designated the delta variant a variant of concern (VOC), the fourth variant to receive this designation.
Watch our on-demand webinar | During the past year, laboratories across the globe have joined together to take up the fight against COVID19 by rapidly launching clinical diagnostic assays to detect affected individuals and ultimately help curb the spread of the disease.
Currently the CDC recommends that any fully vaccinated person who experiences symptoms consistent with COVID-19 be tested for SARS-CoV-2 if indicated. That leads to the question can COVID-19 vaccinations cause false positives? Here’s what we know.
Watch Our Webinar to Expand Your Single-Cell Opportunities | Biological resolution at the level of individual cells is powering the next phase of precision health. Honeycomb is developing a new paradigm in single-cell technology — integrating a sample storage solution within single-cell profiling.